diff --git a/src/App/App.css b/src/App/App.css
index d9bf4cd83af6643eed366e544b0559942ac0d203..325049cbcab4ed632050065597ffac5f8b0eeb9d 100644
--- a/src/App/App.css
+++ b/src/App/App.css
@@ -3555,4 +3555,9 @@ a{
 
 #impressum{
   font-size: x-large  ;
+}
+
+.precyse{
+  padding: 1px ;
+  padding-left: 2px !important;
 }
\ No newline at end of file
diff --git a/src/components/precyse.tsx b/src/components/precyse.tsx
new file mode 100644
index 0000000000000000000000000000000000000000..6a2cbe7a7dc7ec87b8094fc7706475c9aa69b2f9
--- /dev/null
+++ b/src/components/precyse.tsx
@@ -0,0 +1,3 @@
+export default function PreCyse() {
+    return (<span className="underline--magical precyse">  PreCyse </span>
+    )}
\ No newline at end of file
diff --git a/src/contents/description.tsx b/src/contents/description.tsx
index a2fc5d71fa35282388f22796bb94637ec30a9a59..87a2b7cdf2e810c79ab9e8dfa909cd8eecd2dbb7 100644
--- a/src/contents/description.tsx
+++ b/src/contents/description.tsx
@@ -10,7 +10,7 @@ import { Complex } from "../components/Svgs";
 import { ButtonRowTabs } from "../components/Tabs";
 import { useEffect } from "react";
 import PieChart from "../components/Graph";
-
+import PreCyse from "../components/precyse";
 
 export function Description() { 
     const location = useLocation();
@@ -58,7 +58,7 @@ export function Description() {
           
             <section  className="section">
                 <H2 id="Abstract" text="Abstract"/>
-                <p>We are proud to introduce our next-generation prime editing technology <a href="#" className="underline--magical">PreCyse</a>. We aim to develop an innovative gene therapy against cystic fibrosis, tackling the most common mutation ΔF508 of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. We optimize lipid nanoparticles for the efficient and cell-specific delivery of our therapeutic mRNA. Current treatment strategies are limited in terms of speed, precision and effectiveness, often failing to achieve long-lasting improvements. In addition, high costs and limited accessibility of pharmaceuticals contribute to adverse prognosis of many patients. We want to develop a monthly applied which represents a cure that is more advanced and user-friendly compared to other medications due to its longer lasting time, lowering the frequency of use. </p>
+                <p>We are proud to introduce our next-generation prime editing technology <PreCyse/> . We aim to develop an innovative gene therapy against cystic fibrosis, tackling the most common mutation ΔF508 of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene. We optimize lipid nanoparticles for the efficient and cell-specific delivery of our therapeutic mRNA. Current treatment strategies are limited in terms of speed, precision and effectiveness, often failing to achieve long-lasting improvements. In addition, high costs and limited accessibility of pharmaceuticals contribute to adverse prognosis of many patients. We want to develop a monthly applied which represents a cure that is more advanced and user-friendly compared to other medications due to its longer lasting time, lowering the frequency of use. </p>
                 </section>
           </div>